Solid Biosciences Inc. (SLDB:NASDAQ) soared at $10.72, a gain of 25.8%. The stock got featured on our News Catalysts scanner on Wed 24 Feb 21 at 04:52 PM in the 'BIOTECH' category. From Tue 16 Feb 21, the stock recorded 33.33% Up Days and 20.00% Green Days
The stock spiked on Wed 24 Feb 21 at $11.58 with a volume of 6M+.
About Solid Biosciences Inc. (SLDB:NASDAQ)
Solid Biosciences Inc is a life science company engaged in developing therapies for Duchenne muscular dystrophy. Its product candidate, SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles.
Top 10 Gainers:
- RKT (RKT:NYSE), 71.19%
- NanoViricides, Inc. (NNVC:NYSEMKT), 57.58%
- Communications Systems, Inc. (JCS:NASDAQ), 35.33%
- Hovnanian Enterprises, Inc. (HOV:NYSE), 33.18%
- Amyris, Inc. (AMRS:NASDAQ), 27.39%
- Fortress Biotech, Inc. (FBIO:NASDAQ), 26.03%
- Solid Biosciences Inc. (SLDB:NASDAQ), 25.82%
- Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ), 24.3%
- Cango Inc. (CANG:NYSE), 20.83%
- Super League Gaming, Inc. (SLGG:NASDAQ), 20.78%